These observations support our present findings that the TDLN and spleen express elevated levels of CD4+Nrp-1+ cells, resulting in the promotion of CD4+CD25+Foxp3+ or CD4+Foxp3+Treg expression in IL10−/− tumor-bearing mice. The gene discussed is IL10; the disease is neoplasm.